Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ryerson Holding CorpRYZ · Entity 4782 | Executive Vice President & CFO | September 17, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ryerson Holding Corp
Report date September 17, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,185.367 |
Reported balance
After 2026-09-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-17 · Grant · Acquired 31.558 · Balance 4,185.367 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,232.316 |
Reported balance
After 2026-09-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-17 · Grant · Acquired 69.612 · Balance 9,232.316 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027 and March 31, 2028. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,390.314 |
Reported balance
After 2026-09-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-17 · Grant · Acquired 100.963 · Balance 13,390.314 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2026 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027, March 31, 2028, and March 31, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").
F2: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.
F3: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027.
F4: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027 and March 31, 2028.
F5: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2026 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027, March 31, 2028, and March 31, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2022 Filed Apr 4, 2022 18:28 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value ($0.01 per share) | 1,179.556 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007950 · doc1.xml · nonDerivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,997.556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares received upon the vesting of restricted stock units and shares received upon the vesting of dividend equivalent rights granted in connection with the quarterly dividends declared by Ryerson Holding Corporation (the "Company"). Dividend equivalent rights are subject to the same terms and conditions, including vesting, as the underlying restricted stock units. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 21:02 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 32.1066 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-22-000002 · primary_doc.xml · derivative · entry 3 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,664.2757 Underlying: Common Stock · 32.1066 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the 'Company'). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2021 and outstanding as of March 17, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022, March 31, 2023 and March 31, 2024. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2021 and outstanding as of March 17, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022, March 31, 2023 and March 31, 2024. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 21:02 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 9.268 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-22-000002 · primary_doc.xml · derivative · entry 2 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,366.987 Underlying: Common Stock · 9.268 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the 'Company'). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2020 and outstanding as of March 17, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022 and March 31, 2023. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2020 and outstanding as of March 17, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022 and March 31, 2023. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 21:02 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 3.2468 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-22-000002 · primary_doc.xml · derivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,179.556 Underlying: Common Stock · 3.2468 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the 'Company'). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2019 and outstanding as of March 17, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2019 and outstanding as of March 17, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 23:49 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 40.8822 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-022353 · doc1.xml · derivative · entry 3 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,632.1691 Underlying: Common Stock · 40.8822 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2021 and outstanding as of December 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022, March 31, 2023 and March 31, 2024. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2021 and outstanding as of December 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022, March 31, 2023 and March 31, 2024. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 23:49 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 11.8012 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-022353 · doc1.xml · derivative · entry 2 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,357.719 Underlying: Common Stock · 11.8012 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2020 and outstanding as of December 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022 and March 31, 2023. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2020 and outstanding as of December 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022 and March 31, 2023. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 23:49 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 4.134 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-022353 · doc1.xml · derivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176.3092 Underlying: Common Stock · 4.134 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2019 and outstanding as of December 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2019 and outstanding as of December 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 20:21 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 41.2869 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-21-000001 · primary_doc.xml · derivative · entry 3 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,591.2869 Underlying: Common Stock · 41.2869 shares Expires not disclosed F1 · derivative.exercise_price: (1) Each restricted stock unit represents a contingent right to receive one share of stock of Ryerson Holding Corporation (the "Company"). F2 · shares: (2) Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: (5) The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2021 and outstanding as of September 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022, March 31, 2023 and March 31, 2024. F5 · derivative.expiration_date: (5) The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2021 and outstanding as of September 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022, March 31, 2023 and March 31, 2024. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 20:21 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 11.9178 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-21-000001 · primary_doc.xml · derivative · entry 2 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,345.9178 Underlying: Common Stock · 11.9178 shares Expires not disclosed F1 · derivative.exercise_price: (1) Each restricted stock unit represents a contingent right to receive one share of stock of Ryerson Holding Corporation (the "Company"). F2 · shares: (2) Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: (4) The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2020 and outstanding as of September 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022 and March 31, 2023. F4 · derivative.expiration_date: (4) The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2020 and outstanding as of September 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022 and March 31, 2023. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 20:21 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 4.1752 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-21-000001 · primary_doc.xml · derivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,172.1752 Underlying: Common Stock · 4.1752 shares Expires not disclosed F1 · derivative.exercise_price: (1) Each restricted stock unit represents a contingent right to receive one share of stock of Ryerson Holding Corporation (the "Company"). F2 · shares: (2) Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: (3) The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2019 and outstanding as of September 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022. F3 · derivative.expiration_date: (3) The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2019 and outstanding as of September 16, 2021. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2022. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantStock Options · Derivative | 7,500 | $0.00 Strike: $16.50 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · derivative · entry 9 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F9 · derivative.exercise_date: See Exhibit 99.1. F9 · derivative.expiration_date: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | GrantRestricted Stock Units · Derivative | 11,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · derivative · entry 8 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,550 Underlying: Common Stock · 11,550 shares Expires not disclosed F3 · derivative.exercise_price: See Exhibit 99.1. F8 · derivative.exercise_date: See Exhibit 99.1. F8 · derivative.expiration_date: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionRestricted Stock Units · Derivative | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · derivative · entry 7 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,334 Underlying: Common Stock · 1,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: See Exhibit 99.1. F4 · price: See Exhibit 99.1. F7 · derivative.exercise_date: See Exhibit 99.1. F7 · derivative.expiration_date: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionRestricted Stock Units · Derivative | 1,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · derivative · entry 6 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,168 Underlying: Common Stock · 1,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: See Exhibit 99.1. F4 · price: See Exhibit 99.1. F6 · derivative.exercise_date: See Exhibit 99.1. F6 · derivative.expiration_date: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionRestricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · derivative · entry 5 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: See Exhibit 99.1. F4 · price: See Exhibit 99.1. F5 · derivative.exercise_date: See Exhibit 99.1. F5 · derivative.expiration_date: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value $0.01 per share) | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · nonDerivative · entry 4 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: See Exhibit 99.1. F1 · price: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value $0.01 per share) | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · nonDerivative · entry 3 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value $0.01 per share) | 1,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · nonDerivative · entry 2 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:30 UTC | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value $0.01 per share) | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-007537 · doc1.xml · nonDerivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: See Exhibit 99.1. Read SEC document |
| March 31, 2021 Filed Mar 21, 2022 20:47 UTC Amendment | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value $0.01 per share) | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-22-000001 · primary_doc.xml · nonDerivative · entry 3 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares received or that will be received in respect of performance-based restricted stock units granted on March 31, 2018. Each performance-based restricted stock unit became vested on March 31, 2021, which was the later of (i) the third anniversary of the grant date, and (ii) the date the compensation committee certified the achievement of the applicable performance objectives in accordance with the underlying award agreement. The compensation committee certified the achievement of the applicable performance objectives on March 31, 2021. Vested shares will be delivered to the reporting person not later than 60 days following the vesting date. F2 · price: Shares received upon the vesting of restricted stock units. F1 · balance_after: This amendment is being filed to correct an error in the number of shares beneficially owned by the Reporting Person following the acquisitions reported on March 31, 2021. Read SEC document |
| March 31, 2021 Filed Mar 21, 2022 20:47 UTC Amendment | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value $0.01 per share) | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-22-000001 · primary_doc.xml · nonDerivative · entry 2 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Shares received upon the vesting of restricted stock units. F1 · balance_after: This amendment is being filed to correct an error in the number of shares beneficially owned by the Reporting Person following the acquisitions reported on March 31, 2021. Read SEC document |
| March 31, 2021 Filed Mar 21, 2022 20:47 UTC Amendment | Ryerson Holding Corp RYI · Entity 4782 | Exercise / conversionCommon Stock (par value $0.01 per share) | 1,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001841035-22-000001 · primary_doc.xml · nonDerivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Shares received upon the vesting of restricted stock units. F1 · balance_after: This amendment is being filed to correct an error in the number of shares beneficially owned by the Reporting Person following the acquisitions reported on March 31, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.